NASDAQ:VICL

Vical (VICL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.68
$3.15
52-Week Range
N/A
Volume
35,024 shs
Average Volume
1.44 million shs
Market Capitalization
$21.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VICL stock logo

About Vical Stock (NASDAQ:VICL)

Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company was founded in 1987 and is headquartered in San Diego, California.

VICL Stock News Headlines

Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
This song is our story
See More Headlines
Receive VICL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/19/2019
Today
5/06/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:VICL
CUSIP
92560210
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Net Income
$-16,250,000.00
Net Margins
-1,002.10%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.62 million
Book Value
$1.82 per share

Miscellaneous

Free Float
N/A
Market Cap
$21.01 million
Optionable
Not Optionable
Beta
0.32
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Vijay B. Samant (Age 66)
    CEO, Pres & Director
  • Dr. Lawrence Russell Smith (Age 58)
    Sr. VP of Research
  • Mr. Anthony Alan Ramos (Age 52)
    VP, CFO & Chief Accounting Officer
  • Dr. Mammen P. Mammen Jr. (Age 55)
    Former Sr. VP of Clinical Devel.

VICL Stock Analysis - Frequently Asked Questions

How were Vical's earnings last quarter?

Vical Incorporated (NASDAQ:VICL) issued its earnings results on Tuesday, February, 19th. The biotechnology company reported ($0.17) EPS for the quarter, meeting the consensus estimate of ($0.17). The biotechnology company earned $0.12 million during the quarter, compared to analysts' expectations of $0.04 million. Vical had a negative net margin of 1,002.10% and a negative trailing twelve-month return on equity of 29.46%.

What other stocks do shareholders of Vical own?
This page (NASDAQ:VICL) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners